References
Nyakale N, Lockhat Z, Sathekge MM. Nuclear medicine-induced allergic reactions: review article. Current Allergy & Clinical Immunology. 2015;28:10–7.
Silberstein EB, Ryan J. Prevalence of adverse reactions in nuclear medicine. Pharmacopeia Committee of the Society of nuclear medicine. J Nucl Med. 1996;37:185–92.
Laroche ML, Quelven I, Mazère J, Merle L. Adverse reactions to radiopharmaceuticals in France: analysis of the national pharmacovigilance database. Ann Pharmacother. 2015;49:39–47.
Kennedy-Dixon TG, Gossell-Williams M, Cooper M, Trabelsi M, Vinjamuri S. Evaluation of radiopharmaceutical adverse reaction reports to the British Nuclear Medicine Society from 2007 to 2016. J Nucl Med. 2017;58:2010–2.
Giammarile F, Alazraki N, Aarsvold JN, Audisio RA, Glass E, Grant SF, et al. The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer. Eur J Nucl Med Mol Imaging. 2013;40:1932–47.
Niggemann B, Beyer K. Time for a new grading system for allergic reactions? Allergy. 2016;71:135–6.
Wenande E, Garvey LH. Immediate-type hypersensitivity to polyethylene glycols: a review. Clin Exp Allergy. 2016;46:907–22.
Burton DA, Cashman JN. Allergic reaction to nanocolloid during lymphoscintigraphy for sentinel lymph node biopsy. Br J Anaesth. 2003;90:105.
Chicken DW, Mansouri R, Ell PJ, Keshtgar MR. Allergy to technetium-labelled nanocolloidal albumin for sentinel node identification. Ann R Coll Surg Engl. 2007;89:W12–3.
Cotrina-Monroy A, Perez-Iruela JA, Lopez-López A, De Juan R, Rodríguez-Torras ML, Gómez Embuena A. Notification of an adverse effect to human albumin (99m)Tc-nanocolloid. Rev Esp Med Nucl. 2010;29:308–9.
Carbonell A, Escudero AI, Miralles JC, González A, Navarro C, Cardona P, et al. Anaphylaxis due to Poloxamer 238. J Investig Allergol Clin Immunol. 2018;28:419–20.
Acknowledgements
We thank Aurore Gouraud for her kind advice and assistance.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they do not have a conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
Informed consent for the publication was obtained from the patient described in this report.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Skanjeti, A., Darcissac, C., Jaulent, C. et al. Grade 3 anaphylactic shock after administration of [99mTc]-labeled nanocolloidal albumin (Nanocoll®) for sentinel node scintigraphy. Eur J Nucl Med Mol Imaging 46, 1214–1215 (2019). https://doi.org/10.1007/s00259-019-04311-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-019-04311-w